Stephen Ray Mitchell - Director, Vanda Pharmaceuticals Inc
As of June 21, 2022
What is Stephen Ray Mitchell's Net Worth?
The current estimated net worth of Vanda Pharmaceuticals Inc's Director, Stephen Ray Mitchell, is estimated to be about $496.36K . Stephen Ray Mitchell owns about 6,515 units of Vanda Pharmaceuticals Inc common stock. In the last 2 years at Vanda Pharmaceuticals Inc, Stephen Ray Mitchell has sold an estimated value of $442.69K worth.
What is Stephen Ray Mitchell's Past Insider Trading?
Stephen Ray Mitchell's largest purchase order was 19,109 units , worth over $229.94K on September 13, 2021. Stephen Ray Mitchell's largest sale order was 19,109 units , worth over $319.98K on September 13, 2021. In total, Stephen Ray Mitchell has made about 7 transactions over 2 years of their time at Vanda Pharmaceuticals Inc. Stephen Ray Mitchell usually trades in June, with the busiest year in 2021. The most recent transaction was a sale order of 2,700 units , worth over $25.59K on June 14, 2022.
Stephen Ray Mitchell
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Stephen Ray Mitchell's' Mailing Address?
- Mailing address is C/o Vanda Pharmaceuticals Inc. 2200 Pennsylvania Ave., Suite 300e Washington DC 20037 DC
Vanda Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Mihael H. Polymeropoulos, M.D. | 2020 | $746,235 | - | $679,200 | $795,830 | $656,687 | $35,468 | $2,913,420 |
| Mihael H. Polymeropoulos, M.D. | 2019 | $721,000 | - | $1,237,200 | $1,610,154 | $675,000 | $34,783 | $4,278,137 |
| Mihael H. Polymeropoulos, M.D. | 2018 | $700,000 | - | $1,131,000 | $1,456,406 | $700,000 | $37,322 | $4,024,728 |
| James P. Kelly | 2020 | $124,057 | - | - | - | - | $16,217 | $140,274 |
| James P. Kelly | 2019 | $493,370 | - | $618,600 | $805,077 | $288,622 | $42,741 | $2,248,410 |
| James P. Kelly | 2018 | $479,000 | - | $754,000 | $832,232 | $299,375 | $36,778 | $2,401,385 |
| Kevin Moran | 2020 | $324,693 | - | $331,101 | $427,779 | $200,000 | $36,126 | $1,319,699 |
| Joakim Wijkstrom | 2020 | $506,422 | - | $339,600 | $397,915 | $250,679 | $29,269 | $1,523,885 |
| Aranthan "AJ" Jones II | 2020 | $406,104 | - | $339,600 | $397,915 | $201,021 | $33,677 | $1,378,317 |
| Timothy Williams | 2020 | $400,000 | - | $339,600 | $397,915 | $200,000 | $41,546 | $1,379,061 |
| Timothy Williams | 2019 | $379,315 | - | $618,600 | $805,077 | $177,520 | $42,342 | $2,022,854 |
| Timothy Williams | 2018 | $144,886 | $40,000 | $643,500 | $1,086,894 | $71,918 | $15,658 | $2,002,856 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1347178/000134717821000008/vnda-20210422xdef14a.htm
What are Vanda Pharmaceuticals Inc's Past Insider Trades?
Vanda Pharmaceuticals Inc's most recent insider trade came on June 14, 2022 by Stephen Ray Mitchell who sold 2,700 units worth $25.59K . In the last 16 years, insiders at Vanda Pharmaceuticals Inc have sold an estimated value of $295.94M and bought an estimated value of $28.25M worth of shares. Insider trading is most common in June, with the busiest year in 2006. The most active traders at the company are Mihael Polymeropoulos, President and CEO, James P. Kelly, EVP & Chief Financial Officer, and Richard W Dugan, Director .
Vanda Pharmaceuticals Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||